2025 ESMO Prostate Cancer Highlights - Top-Institutions - MDSpire

2025 ESMO Prostate Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from ESMO 2025

  • November 17, 2025

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Genitourinary Oncology
    • Clinical Trials
    • Precision Medicine

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Genitourinary Oncology
    • Translational Research
    • Clinical Trials

  • #3

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Urology
    • Oncology
    • Precision Medicine

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Genitourinary Oncology
    • Clinical Trials
    • Precision Oncology

Original Source(s)

2025 ESMO Prostate Cancer Highlights

  • November 17, 2025

Related Content

Accelerated Immuno Chemoradiotherapy Based on FDG-PET/CT for Small Volume in Locally Advanced NSCLC (PACCELIO) – A Phase II Multicenter Randomized Open-Label Trial Protocol

Will Circulating Tumor DNA Help Predict HPV-Related Throat Cancer?

A Keck Medicine of USC head and neck surgeon discusses circulating HPV DNA as a biomarker that could help make more individualized treatment decisions.

  • by

  • March 24, 2026

  • 5 min
Case Report: Primary sciatic leiomyosarcoma in a patient with neurofibromatosis type 1